This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $566,810.00 to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, MA, to support research on the neural regulation of small cell lung cancer progression. The award period is from September 1, 2023 to August 31, 2025. Brigham & Women's Hospital Inc. has previously conducted biomedical research and provided specialized services to federal agencies through contracts and grants. The grant may involve collaboration with the hospital's parent organization, Partners Healthcare System Incorporated, which has also served as a subrecipient on various federal research grants.
Generated 3/26/24, 9:25 AM